Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

Safety Information

909904

Sigma-Aldrich

4arm-poly(lactide-co-glycolide)

average Mn 38,000-60,000, lactide:glycolide 55:45

Synonym(s):

4 arm PLGA, 4 arm-PLGA, 4arm-PLGA

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Linear Formula:
C5H8O4((((C3H4O2)x(C2H2O2)y)m)H)4
UNSPSC Code:
12162002
NACRES:
NA.23

form

powder or chunks

feed ratio

lactide:glycolide 55:45

mol wt

average Mn 38,000-60,000

color

white to tan

storage temp.

−20°C

Related Categories

Application

Biocompatible and biodegradable polymer. Can be used in the formation of nanoparticles for drug delivery. The multi-arm molecular structure might promote high drug loading, superior colloidal stability, as well as long circulation time.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

909904-BULK:
909904-VAR:
909904-500MG:

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCK8313

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Xiuxiu Wang et al.
Biomacromolecules, 19(4), 1368-1373 (2018-03-20)
PLGA, a copolymer of lactide and glycolide, is one of the most used biodegradable polymers that find a wide range of biomedical applications including drug delivery and tissue engineering. However, in spite of remarkable advancement, nanotherapeutics based on PLGA might
R Gref et al.
Science (New York, N.Y.), 263(5153), 1600-1603 (1994-03-18)
Injectable nanoparticulate carriers have important potential applications such as site-specific drug delivery or medical imaging. Conventional carriers, however, cannot generally be used because they are eliminated by the reticulo-endothelial system within seconds or minutes after intravenous injection. To address these

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service